Scott Murray Weiss
5Patents
4h-index
12Co-inventors
46Inventor score
Filing activity: Sep 27, 1999 → Dec 20, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6197788A | (-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders | Human Necessities | 19 | Expired |
| US7405219B2 | Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists | Human Necessities | 19 | Active |
| US7141575B2 | Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists | Human Necessities | 18 | Expired |
| US7589097B2 | Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists | Human Necessities | 12 | Active |
| US7452894B2 | Purine derivatives as purinergic receptor antagonists | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.